Stage IA Breast Cancer Terminated Phase 1 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00450879Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTreatment